Comparison of Ranibizumab Alone Versus Ranibizumab with Targeted Retinal Laser for Branch Retinal Vein Occlusion with Macular Edema

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2019 Jun 27

PMID 31238421

Citations 9

Authors

Siddhi Goel

Atul Kumar

Raghav D Ravani

Parijat Chandra

Mahesh Chandra

Vinod Kumar

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the effect of ultra-widefield fluorescein angiography (UWFFA)-guided targeted retinal photocoagulation (TRP) in branch retinal vein occlusion (BRVO) with macular edema after intravitreal Ranibizumab (RBZ).

Methods: 33 eyes of 32 treatment naïve patients diagnosed as BRVO with macular edema were prospectively randomized to 0.5 mg Ranibizumab only (RBZ group) (n = 17) or Ranibizumab with UWFFA-guided laser (RBZ + TRP group) (n = 16). Both groups received three injections at monthly intervals and PRN henceforth. RBZ + TRP group additionally underwent UWFFA-guided TRP of peripheral capillary nonperfusion areas 1 week post injection. Outcome measures included improvement in visual acuity, central subfoveal thickness (CST), and the number of injections required with a minimum follow-up of 9 months.

Results: Both groups showed significant improvement in mean BCVA (25.7 ± 8.19 letters, P < 0.001 vs. 23.38 ± 7.56 letters, P < 0.001; in RBZ and RBZ + TRP group, respectively) and reduction in mean central subfoveal thickness (379.12 ± 242.7 μm, P < 0.001 vs. 253.75 ± 137.9 μm, P < 0.001 in RBZ and RBZ + TRP group, respectively) at 9 months. The number of injections in the RBZ group (5.76 ± 1.3) was significantly greater than RBZ + TRP (4.06 ± 0.99) (P < 0.001). Both groups had significant improvement in contrast sensitivity and mean deviation on visual fields; however, the difference between the groups was not significant (P = 0.62 and P = 0.79, respectively).

Conclusion: UWFFA-guided TRP reduced the number of injections of Ranibizumab in patients having BRVO with macular edema, while maintaining similar benefits in the improvement of BCVA, central subfoveal thickness without deleterious effect on the visual field, and contrast sensitivity.

Citing Articles

The Diagnosis and Treatment of Branch Retinal Vein Occlusions: An Update.

Darabus D, Darabus R, Munteanu M Biomedicines. 2025; 13(1).

PMID: 39857689 PMC: 11763247. DOI: 10.3390/biomedicines13010105.

A hypothetical therapeutic effect of light peripheral panretinal photocoagulation in neovascular age-related macular degeneration.

Mansour A, Tripathy K, Battaglia Parodi M Med Hypothesis Discov Innov Ophthalmol. 2023; 11(3):137-143.

PMID: 37641639 PMC: 10445313. DOI: 10.51329/mehdiophthal1457.

Clinical utility of ultra-widefield fluorescein angiography and optical coherence tomography angiography for retinal vein occlusions.

Tan T, Ibrahim F, Chandrasekaran P, Teo K Front Med (Lausanne). 2023; 10:1110166.

PMID: 37359003 PMC: 10285461. DOI: 10.3389/fmed.2023.1110166.

Effects of Ranibizumab combined with laser photocoagulation on macular volume and best corrected visual acuity in patients with macular edema secondary to ischemic retinal vein occlusion.

Liang J, Xiong T, Chen H, Tao R, Cao L Pak J Med Sci. 2023; 39(2):385-389.

PMID: 36950445 PMC: 10025720. DOI: 10.12669/pjms.39.2.7040.

Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy.

Lin Z, Deng A, Hou N, Gao L, Zhi X Front Endocrinol (Lausanne). 2023; 14:1108394.

PMID: 36936172 PMC: 10018161. DOI: 10.3389/fendo.2023.1108394.

References

Krohne T, Liu Z, Holz F, Meyer C . Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans. Am J Ophthalmol. 2012; 154(4):682-686.e2. DOI: 10.1016/j.ajo.2012.03.047. View

Manivannan A, Plskova J, Farrow A, McKay S, Sharp P, Forrester J . Ultra-wide-field fluorescein angiography of the ocular fundus. Am J Ophthalmol. 2005; 140(3):525-7. DOI: 10.1016/j.ajo.2005.02.055. View

Tan C, Chew M, van Hemert J, Singer M, Bell D, Sadda S . Measuring the precise area of peripheral retinal non-perfusion using ultra-widefield imaging and its correlation with the ischaemic index. Br J Ophthalmol. 2015; 100(2):235-9. DOI: 10.1136/bjophthalmol-2015-306652. View

Prasad P, Oliver S, Coffee R, Hubschman J, Schwartz S . Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion. Ophthalmology. 2010; 117(4):780-4. DOI: 10.1016/j.ophtha.2009.09.019. View

Tomomatsu Y, Tomomatsu T, Takamura Y, Gozawa M, Arimura S, Takihara Y . Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions. Acta Ophthalmol. 2015; 94(3):e225-30. DOI: 10.1111/aos.12721. View

Campochiaro P, Hafiz G, Shah S, Nguyen Q, Ying H, Do D . Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther. 2008; 16(4):791-9. DOI: 10.1038/mt.2008.10. View

Campochiaro P, Bhisitkul R, Shapiro H, Rubio R . Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology. 2012; 120(4):795-802. DOI: 10.1016/j.ophtha.2012.09.032. View

Tan C, Chew M, Lim L, Sadda S . Advances in retinal imaging for diabetic retinopathy and diabetic macular edema. Indian J Ophthalmol. 2016; 64(1):76-83. PMC: 4821126. DOI: 10.4103/0301-4738.178145. View

Noma H, Minamoto A, Funatsu H, Tsukamoto H, Nakano K, Yamashita H . Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2005; 244(3):309-15. DOI: 10.1007/s00417-004-1087-4. View

10.

Wessel M, Aaker G, Parlitsis G, Cho M, DAmico D, Kiss S . Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina. 2011; 32(4):785-91. DOI: 10.1097/IAE.0b013e3182278b64. View

11.

Campochiaro P, Heier J, Feiner L, Gray S, Saroj N, Rundle A . Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010; 117(6):1102-1112.e1. DOI: 10.1016/j.ophtha.2010.02.021. View

12.

Heier J, Campochiaro P, Yau L, Li Z, Saroj N, Rubio R . Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012; 119(4):802-9. DOI: 10.1016/j.ophtha.2011.12.005. View

13.

K Muqit M, Marcellino G, Henson D, Young L, Patton N, Charles S . Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol. 2011; 91(3):251-8. DOI: 10.1111/j.1755-3768.2011.02307.x. View

14.

Wykoff C, Ou W, Wang R, Brown D, Cone C, Zamora D . Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial. Ophthalmology. 2017; 124(6):919-921. DOI: 10.1016/j.ophtha.2017.01.049. View

15.

Bakri S, Snyder M, Reid J, Pulido J, Ezzat M, Singh R . Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology. 2007; 114(12):2179-82. DOI: 10.1016/j.ophtha.2007.09.012. View

16.

Campochiaro P, Hafiz G, Mir T, Scott A, Solomon S, Zimmer-Galler I . Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial. Ophthalmology. 2015; 122(7):1426-37. PMC: 10020833. DOI: 10.1016/j.ophtha.2015.04.006. View